These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22525563)

  • 1. The antioxidant properties of high-density lipoproteins in atherosclerosis.
    Mackness B; Mackness M
    Panminerva Med; 2012 Jun; 54(2):83-90. PubMed ID: 22525563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
    Moradi H; Pahl MV; Elahimehr R; Vaziri ND
    Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
    Kontush A; de Faria EC; Chantepie S; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):526-33. PubMed ID: 14739123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL capacity to inhibit LDL oxidation in well-trained triathletes.
    Brites F; Zago V; Verona J; Muzzio ML; Wikinski R; Schreier L
    Life Sci; 2006 May; 78(26):3074-81. PubMed ID: 16488445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual role for lecithin:cholesterol acyltransferase (EC 2.3.1.43) in lipoprotein oxidation.
    McPherson PA; Young IS; McEneny J
    Free Radic Biol Med; 2007 Dec; 43(11):1484-93. PubMed ID: 17964419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation.
    Hine D; Mackness B; Mackness M
    IUBMB Life; 2012 Feb; 64(2):157-61. PubMed ID: 22184096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice.
    Ng CJ; Hama SY; Bourquard N; Navab M; Reddy ST
    Mol Genet Metab; 2006 Dec; 89(4):368-73. PubMed ID: 16935014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in apolipoprotein A- I and it's anti-atherosclerosis properties].
    Li M; Liu ZM
    Sheng Wu Gong Cheng Xue Bao; 2003 Jul; 19(4):387-91. PubMed ID: 15969051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo exchange of cholesteryl esters from low density lipoproteins to high density lipoproteins.
    Nestel PJ; Billington T
    Artery; 1980; 7(5):395-403. PubMed ID: 7213024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel lecithin-cholesterol acyltransferase antioxidant activity prevents the formation of oxidized lipids during lipoprotein oxidation.
    Vohl MC; Neville TA; Kumarathasan R; Braschi S; Sparks DL
    Biochemistry; 1999 May; 38(19):5976-81. PubMed ID: 10320323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
    Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL
    Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-oxidant properties of high-density lipoprotein and atherosclerosis.
    Podrez EA
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):719-25. PubMed ID: 20374263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection.
    Escolà-Gil JC; Rotllan N; Julve J; Blanco-Vaca F
    Atherosclerosis; 2009 Oct; 206(2):321-7. PubMed ID: 19362310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
    Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ
    J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
    Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protective effect of high density lipoproteins, their subfractions and lecithin-cholesterol-acyltransferases on the peroxidation modification of low density lipoproteins].
    Klimov AN; Nikiforova AA; Pleskov VM; Kuz'min AA; Kalashnikova NN
    Biokhimiia; 1989 Jan; 54(1):118-23. PubMed ID: 2719985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of high-density lipoproteins.
    Dastani Z; Engert JC; Genest J; Marcil M
    Curr Opin Cardiol; 2006 Jul; 21(4):329-35. PubMed ID: 16755202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.
    Noto H; Hara M; Karasawa K; Iso-O N; Satoh H; Togo M; Hashimoto Y; Yamada Y; Kosaka T; Kawamura M; Kimura S; Tsukamoto K
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):829-35. PubMed ID: 12649088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.